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Relevant Information
Exposure to hazardous drugs may 
occur through inhalation, skin absorp-
tion, ingestion, or injection.6
Adverse health effects from hazard-
ous drug exposure may include harm 
to internal organs, damage to the 
reproductive system, genetic damage, 
birth defects, and cancer.6
About 8 million U.S. healthcare 
workers are potentially exposed to 
hazardous drugs, including pharmacy 
and nursing personnel, physicians, 
environmental services workers, work-
ers in research laboratories, veterinary 
care workers, and shipping and receiv-
ing personnel.7  
Modern society is fortunate to have powerful treatments 
available for a wide range of medical conditions. However, 
some useful medications can also have serious side 
effects. When using these drugs for medical treatment, 
doctors carefully control the dose and monitor the patient 
to minimize harmful consequences. But the doctors, 
nurses, pharmacists, and other healthcare workers who 
handle these medications are also being exposed and may 
also demonstrate adverse health effects.1
Hazardous drugs include drugs used for chemo-
therapy, antiviral drugs, hormones, and some 
immunosuppressant drugs—all of which may have 
damaging effects on the body. When these drugs 
must be prepared and administered, there are work-
place best practices that can minimize potentially 
harmful exposure. These include the use of engineer-
ing controls such as biological safety cabinets, closed 
system transfer devices, needleless systems, and per-
sonal protective equipment such as gloves, masks, 
and gowns.  In order to use this equipment appropri-
ately and effectively, healthcare workers need to know 
which drugs pose a hazard.2 
Impact
NIOSH List of Hazardous Drugs in Healthcare 
Settings Allows Healthcare Workers to Minimize 
Exposure and Reduce Health Risks
  A pharmacist uses personal protective 
equipment and engineering controls while 
preparing a potentially toxic medication. Photo 
by UMHealthSystem, downloaded from Flickr.
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Starting in 2000, the National Institute for Occupational Safety and Health (niosh) began 
working with multiple partners and stakeholders to address the issue of occupational 
exposure to hazardous drugs. The niosh Hazardous Drug Committee—with representatives 
from nursing and pharmacy professional associations, federal agencies, pharmaceutical 
companies, health and safety professionals, manufacturers of safety equipment, and 
academia—developed recommendations for how to minimize exposure when working with 
hazardous drugs. 
Impact
In order to disseminate these recommendations, in 2004 niosh published a niosh Alert 
and list of hazardous drugs with active input from partners in the healthcare industry, 
the pharmaceutical industry, and federal agencies. The list was updated in 2010 and will 
be updated periodically as new drugs become available. This list is a unique resource—
the only current government-supported list of hazardous drugs in the U.S.—and is 
heavily referenced by workers throughout the healthcare industry. Since 2004 the website 
containing this information has been accessed over 200,000 times, with 27,000 of these 
visits in the 9 month period from October 2010 to June 2011.3 
The value of this niosh Alert and list is demonstrated by the response it has received. 
In April 2011 the state of Washington passed legislation directing the Washington 
Department of Labor and Industry to use this information as the basis for statewide rules 
on the handling of hazardous drugs.4 In that same month, a joint letter was issued by the 
Occupational Safety and Health Administration, The Joint Commission, and niosh to 
all hospitals and healthcare employers in the nation. The letter describes the niosh Alert 
and hazardous drug list, and encourages employers to use this resource to protect their 
employees.5 Because this information is easily accessible at www.cdc.gov/niosh/topics/
hazdrug/, healthcare workers can become active collaborators with employers in reducing 
their exposure to these occupational hazards, decreasing risks to their own health while 
they care for the health of others.
Visit the NIOSH Web site (www.cdc.gov/niosh) for more information about Hazardous Drug research. Authors of 
the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings—Barbara MacKenzie, Thomas 
Connor, D. Gayle DeBord, James O’Callaghan, and Douglas Trout; NIOSH—received a 2011 Bullard-Sherwood r2p 
Award in the Knowledge category. 
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